CSI Market
Sign In | Register

Telix Pharmaceuticals Ltd (TLX) Annual Balance Sheets

Annual · GAAP · USD millions
Access TLX quarterly Balance Sheets →
Balance sheet data covering Telix Pharmaceuticals Ltd– offers a view into how Dec 31 2025's financial position has changed alongside business activity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024)
Assets
Cash And Cash Equivalents141.87
Current Tax Assets Current6.04
Cash & Short-term Investments147.00
Trade & Other Current Receivables (IFRS combined total)129.20
Notes Receivable, Current37.08
Other Current Assets153.55
Total Current Assets330.28
Equipment/Property/Plant Net58.66
Goodwill net198.99
Intangible Assets592.82
Deferred Tax Assets59.35
Intangible AssetsAnd Goodwill592.82
Trade And Other Current Receivables129.20
Other Current Assets16.09
Noncurrent Financial Assets37.09
Rightofuse Assets56.95
Noncurrent Assets833.71
Total Assets1,163.99
Liabilities
Accounts Payable150.35
Short-term Debt391.91
Current Provisions0.56
Total Current Liabilities231.62
Long-term debt3.52
Total Long-term Debt3.52
Deferred Tax Liabilities, Net LI44.71
Noncurrent Provisions9.18
Current Tax Liabilities Current30.74
Current Contract Liabilities0.40
Current Lease Liabilities5.55
Current Contingent Consideration11.54
Current Employee Benefit Obligations19.37
Noncurrent Contract Liabilities0.00
Noncurrent Lease Liabilities56.53
Total Liabilities748.61
Stockholders' Equity
Other Equity415.38
Common Stockholder's Equity415.38
Total Stockholder's Equity415.38
Liabilities & Stockholder's Equity1,163.99
4 historic quarters locked

Sign in to unlock the full Telix Pharmaceuticals Ltd balance sheet history.

Sign In Create Free Account

About Telix Pharmaceuticals Ltd Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 20-F (Period: 20251231)
  • Filed with the SEC: February 19, 2026
  • Source: tlx-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-009943

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.